Summary: Our technology editor examines the long-term fallout after Samsung's flagship smartphone is pulled from production. The Food and Drug Administration's approval of a new drug for muscular dystrophy proves controversial and Matt Kaplan explains why higher-class people spend less time looking at their fellow humans
